Myeloid cell path to malignancy: insights into liver cancer
Authors:
Open Access
- 26 March 2025
- journal article
- review article
- Published by Elsevier in Trends in Cancer
- Vol. 11 (6) , 591-610
Abstract
No abstract availableKeywords
Funding Information
- KWF Kankerbestrijding (KWF 12049)
- Ministerie van Volksgezondheid, Welzijn en Sport
- Cancer Genomics Centre
- Oncode Institute
This publication has 142 references indexed in Scilit:
- Targeting Transcription Factors in Cancer: From “Undruggable” to “Druggable”2022
- Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR StudyHepatology, 2020
- Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell–Mediated Cytotoxicity Against Hepatocellular CarcinomaHepatology, 2019
- ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced FibrosisHepatology, 2019
- Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseHepatology Communications, 2018
- Projections of primary liver cancer to 2030 in 30 countries worldwideHepatology, 2017
- Liver inflammation abrogates immunological tolerance induced by Kupffer cellsHepatology, 2015
- Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and CHepatology, 2014
- Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver†Hepatology, 2009
- The Hepatic Microvascular System in Health and Its Response to ToxicantsThe Anatomical Record, 2008